Sigma-Aldrich has completed its acquisition of BioReliance from Avista Capital Partners for $350m. BioReliance's services will be folded into Sigma-Aldrich's SAFC custom manufacturing and services business unit.
Maryland Daily Record
Wednesday 1 February 2012
SAFC gets BioReliance
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment